In conclusion, the majority of myeloid neoplasm-associated gene variants in AA patients affected TET2, ASXL1 and MPL, and epigenetic- and signal transduction pathway-related genes were the most commonly involved. The gene discussed is TET2; the disease is myeloid neoplasm.